Charles-Hugo Marquette

[The biological rationale for immunotherapy in cancer].

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.

Lung Cancer Screening, Towards a Multidimensional Approach: Why and How?

The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again.

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

[Tumor banks and complex data management: Current and future challenges].

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables.

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution.

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.

[Primary spontaneous pneumothorax: We have time to get some fresh air…].

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d'Azur, Nice, France).